Technician - Telemetry Monitor I
AbbVie
Summary
Maintain accurate and complete source data in PIMS and/or other source documents and assist in the resolution of source discrepancies or issues, as appropriate.
Job description
Responsibilities
- Review protocols and provide input on study-specific activities that impact technical areas of responsibility and unit workflow in relation to all studies planned to occur concurrently.
- Perform study protocol related activities, i.e. blood drawing, ECGs, meals, etc., as assigned
- Facilitate proper telemetry monitoring system set-up and preparation of telemetry transmitters and related documentation as assigned.
- Perform continuous cardiac telemetry monitoring of study subjects, as required by the study protocols.
- Perform telemetry data review in the telemetry monitoring system and generate holter reports, as appropriate.
- Maintain safety and confidentiality of study subjects throughout the study and ensure that staff can recognize safety related information as appropriate.
- Mentor Telemetry Monitor Technicians and Clinical Research Technicians, identify training needs and conducts training as appropriate.
- Participate in quality and compliance report projects and provide feedback as subject matter expert.
Requirements
- Associate Degree or equivalent relevant experience
- 2-3 years of medical/lab technology experience and/or 2-6 years of clinical research/RT experience
- Documented proficiency in Cardiac Arrhythmia recognition/high level of ECG recognition skills
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.